Bicycle Therapeutics (BCYC) Accumulated Depreciation & Amortization (2018 - 2025)
Bicycle Therapeutics (BCYC) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $1.8 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Accumulated Depreciation & Amortization fell 18.18% year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Sep 2025, down 18.18%, and an annual FY2024 reading of $7.2 million, up 10.77% over the prior year.
- Accumulated Depreciation & Amortization was $1.8 million for Q3 2025 at Bicycle Therapeutics, down from $3.3 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $10.4 million in Q2 2023 and bottomed at $1.6 million in Q1 2025.
- Average Accumulated Depreciation & Amortization over 5 years is $4.4 million, with a median of $4.5 million recorded in 2021.
- The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 101.58% in 2023, then plummeted 68.4% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $4.8 million in 2021, then dropped by 22.92% to $3.7 million in 2022, then soared by 75.68% to $6.5 million in 2023, then grew by 10.77% to $7.2 million in 2024, then crashed by 75.0% to $1.8 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for BCYC at $1.8 million in Q3 2025, $3.3 million in Q2 2025, and $1.6 million in Q1 2025.